Log In
Print
BCIQ
Print
Print this Print this
 

VBP15

  Manage Alerts
Collapse Summary General Information
Company ReveraGen BioPharma Inc.
DescriptionDissociative glucocorticoid and inhibitor of NF-kappa B (NF-kB)
Molecular Target NF-kappa B (NF-kB)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today